Li Ren , Dexiang Zhu , Jin Gu , Baoqing Jia , Jin Li , Xinyu Qin , Xishan Wang , Ruihua Xu , Yingjiang Ye , Suzhan Zhang , Zhongtao Zhang , Jianmin Xu , Jia Fan , China CRLM Guideline Group, Chinese College of Surgeons, Chinese Medical Doctor Association, Section of Gastrointestinal Surgery, Branch of Surgery, Chinese Medical Association, Section of Colorectal & Anal Surgery, Branch of Surgery, Chinese Medical Association, Colorectal Cancer Professional Committee, Chinese Anti-Cancer Association, Colorectal Cancer Professional Committee, Chinese Medical Doctor Association, Colorectal Cancer Expert Committee, Chinese Society of Clinical Oncology, Chinese Society of Colon & Rectal Surgeons, Chinese College of Surgeons, Chinese Medical Doctor Association, Metastasis Research Committee, Anorectal Branch of Chinese Medical Doctor Association, Colorectal Oncology Group, Branch of Oncology, Chinese Medical Association, Metastatic Tumor Therapy Branch of China International Exchange and Promotive Association for Medical and Health Care, Colorectal Disease Branch of China International Exchange and Promotive Association for Medical and Health Care
{"title":"中国结直肠肝转移诊断与综合治疗指南(V. 2023)","authors":"Li Ren , Dexiang Zhu , Jin Gu , Baoqing Jia , Jin Li , Xinyu Qin , Xishan Wang , Ruihua Xu , Yingjiang Ye , Suzhan Zhang , Zhongtao Zhang , Jianmin Xu , Jia Fan , China CRLM Guideline Group, Chinese College of Surgeons, Chinese Medical Doctor Association, Section of Gastrointestinal Surgery, Branch of Surgery, Chinese Medical Association, Section of Colorectal & Anal Surgery, Branch of Surgery, Chinese Medical Association, Colorectal Cancer Professional Committee, Chinese Anti-Cancer Association, Colorectal Cancer Professional Committee, Chinese Medical Doctor Association, Colorectal Cancer Expert Committee, Chinese Society of Clinical Oncology, Chinese Society of Colon & Rectal Surgeons, Chinese College of Surgeons, Chinese Medical Doctor Association, Metastasis Research Committee, Anorectal Branch of Chinese Medical Doctor Association, Colorectal Oncology Group, Branch of Oncology, Chinese Medical Association, Metastatic Tumor Therapy Branch of China International Exchange and Promotive Association for Medical and Health Care, Colorectal Disease Branch of China International Exchange and Promotive Association for Medical and Health Care","doi":"10.1016/j.cson.2023.100013","DOIUrl":null,"url":null,"abstract":"<div><p>The liver is the main target organ for hematogenous metastases of colorectal cancer, and colorectal liver metastasis is one of the most difficult and challenging situations in the treatment of colorectal cancer. In order to improve the diagnosis and comprehensive treatment in China, the Guidelines have been edited and revised for several times since 2008, including the overall evaluation, personalized treatment goals and comprehensive treatments, to prevent the occurrence of liver metastases, increase the local damage rate of liver metastases, prolong long-term survival, and improve quality of life. The revised Guideline version 2023 includes the diagnosis and followup, prevention, multidisciplinary team (MDT), surgery and local ablative treatment, neoadjuvant and adjuvant therapy, and comprehensive treatment, with stateoftheart experience and findings, detailed content, and strong operability.</p></div>","PeriodicalId":100278,"journal":{"name":"Clinical Surgical Oncology","volume":"2 2","pages":"Article 100013"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (V. 2023)\",\"authors\":\"Li Ren , Dexiang Zhu , Jin Gu , Baoqing Jia , Jin Li , Xinyu Qin , Xishan Wang , Ruihua Xu , Yingjiang Ye , Suzhan Zhang , Zhongtao Zhang , Jianmin Xu , Jia Fan , China CRLM Guideline Group, Chinese College of Surgeons, Chinese Medical Doctor Association, Section of Gastrointestinal Surgery, Branch of Surgery, Chinese Medical Association, Section of Colorectal & Anal Surgery, Branch of Surgery, Chinese Medical Association, Colorectal Cancer Professional Committee, Chinese Anti-Cancer Association, Colorectal Cancer Professional Committee, Chinese Medical Doctor Association, Colorectal Cancer Expert Committee, Chinese Society of Clinical Oncology, Chinese Society of Colon & Rectal Surgeons, Chinese College of Surgeons, Chinese Medical Doctor Association, Metastasis Research Committee, Anorectal Branch of Chinese Medical Doctor Association, Colorectal Oncology Group, Branch of Oncology, Chinese Medical Association, Metastatic Tumor Therapy Branch of China International Exchange and Promotive Association for Medical and Health Care, Colorectal Disease Branch of China International Exchange and Promotive Association for Medical and Health Care\",\"doi\":\"10.1016/j.cson.2023.100013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The liver is the main target organ for hematogenous metastases of colorectal cancer, and colorectal liver metastasis is one of the most difficult and challenging situations in the treatment of colorectal cancer. In order to improve the diagnosis and comprehensive treatment in China, the Guidelines have been edited and revised for several times since 2008, including the overall evaluation, personalized treatment goals and comprehensive treatments, to prevent the occurrence of liver metastases, increase the local damage rate of liver metastases, prolong long-term survival, and improve quality of life. The revised Guideline version 2023 includes the diagnosis and followup, prevention, multidisciplinary team (MDT), surgery and local ablative treatment, neoadjuvant and adjuvant therapy, and comprehensive treatment, with stateoftheart experience and findings, detailed content, and strong operability.</p></div>\",\"PeriodicalId\":100278,\"journal\":{\"name\":\"Clinical Surgical Oncology\",\"volume\":\"2 2\",\"pages\":\"Article 100013\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Surgical Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2773160X23000053\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Surgical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2773160X23000053","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (V. 2023)
The liver is the main target organ for hematogenous metastases of colorectal cancer, and colorectal liver metastasis is one of the most difficult and challenging situations in the treatment of colorectal cancer. In order to improve the diagnosis and comprehensive treatment in China, the Guidelines have been edited and revised for several times since 2008, including the overall evaluation, personalized treatment goals and comprehensive treatments, to prevent the occurrence of liver metastases, increase the local damage rate of liver metastases, prolong long-term survival, and improve quality of life. The revised Guideline version 2023 includes the diagnosis and followup, prevention, multidisciplinary team (MDT), surgery and local ablative treatment, neoadjuvant and adjuvant therapy, and comprehensive treatment, with stateoftheart experience and findings, detailed content, and strong operability.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
